Task: Answer the multiple choice question.
Question: Which drug exhibits a -65.807% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: CCCOc1ccc(C(=O)C(CN2CCCC2)c2ccccc2)cc1.Cl
b: Cc1cccc(-n2c(Cc3cc(=O)[nH]c(=O)[nH]3)nnc2SCC(=O)N2CCCCC2)c1
c: CCOC(=O)C1CCCc2c1[nH]c1c(C(N)=O)cccc21
Answer: a. CCCOc1ccc(C(=O)C(CN2CCCC2)c2ccccc2)cc1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOc1ccc(C(=O)C(CN2CCCC2)c2ccccc2)cc1.Cl
CCCOc1ccc(C(=O)C(CN2CCCC2)c2ccccc2)cc1.Cl
2-phenyl-1-(4-propoxyphenyl)-3-pyrrolidin-1-ylpropan-1-one;hydrochloride